MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 63.76 million. The enterprise value is 157.57 million.
| Market Cap | 63.76M |
| Enterprise Value | 157.57M |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 393.58 million shares outstanding. The number of shares has increased by 2.01% in one year.
| Current Share Class | 393.58M |
| Shares Outstanding | 393.58M |
| Shares Change (YoY) | +2.01% |
| Shares Change (QoQ) | +1.92% |
| Owned by Insiders (%) | 10.45% |
| Owned by Institutions (%) | 0.37% |
| Float | 352.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.41 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 3.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 32.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.75, with an EV/FCF ratio of -71.01.
| EV / Earnings | -9.89 |
| EV / Sales | 1.00 |
| EV / EBITDA | 10.75 |
| EV / EBIT | 158.68 |
| EV / FCF | -71.01 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.19.
| Current Ratio | 1.12 |
| Quick Ratio | 0.27 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 5.94 |
| Debt / FCF | -39.22 |
| Interest Coverage | 0.14 |
Financial Efficiency
Return on equity (ROE) is -19.76% and return on invested capital (ROIC) is 0.37%.
| Return on Equity (ROE) | -19.76% |
| Return on Assets (ROA) | 0.30% |
| Return on Invested Capital (ROIC) | 0.37% |
| Return on Capital Employed (ROCE) | 0.65% |
| Revenue Per Employee | 203,048 |
| Profits Per Employee | -20,589 |
| Employee Count | 832 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 2.76 |
Taxes
In the past 12 months, MariMed has paid 9.13 million in taxes.
| Income Tax | 9.13M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.10% in the last 52 weeks. The beta is 2.98, so MariMed's price volatility has been higher than the market average.
| Beta (5Y) | 2.98 |
| 52-Week Price Change | +5.10% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 60.44 |
| Average Volume (20 Days) | 1,136,785 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, MariMed had revenue of 157.16 million and -15.94 million in losses. Loss per share was -0.04.
| Revenue | 157.16M |
| Gross Profit | 60.66M |
| Operating Income | 993,000 |
| Pretax Income | -6.76M |
| Net Income | -15.94M |
| EBITDA | 12.56M |
| EBIT | 993,000 |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 6.14 million in cash and 87.03 million in debt, giving a net cash position of -80.89 million or -0.21 per share.
| Cash & Cash Equivalents | 6.14M |
| Total Debt | 87.03M |
| Net Cash | -80.89M |
| Net Cash Per Share | -0.21 |
| Equity (Book Value) | 73.17M |
| Book Value Per Share | 0.15 |
| Working Capital | 6.19M |
Cash Flow
In the last 12 months, operating cash flow was 1.98 million and capital expenditures -4.20 million, giving a free cash flow of -2.22 million.
| Operating Cash Flow | 1.98M |
| Capital Expenditures | -4.20M |
| Free Cash Flow | -2.22M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 38.60%, with operating and profit margins of 0.63% and -10.14%.
| Gross Margin | 38.60% |
| Operating Margin | 0.63% |
| Pretax Margin | -4.30% |
| Profit Margin | -10.14% |
| EBITDA Margin | 7.99% |
| EBIT Margin | 0.63% |
| FCF Margin | n/a |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.01% |
| Shareholder Yield | -2.01% |
| Earnings Yield | -24.99% |
| FCF Yield | -3.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 3 |